KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Progyny (PGNY) Gains from Sales and Divestitures (2020 - 2021)

Historic Gains from Sales and Divestitures for Progyny (PGNY) over the last 2 years, with Q4 2021 value amounting to $201916.0.

  • Progyny's Gains from Sales and Divestitures rose 31981.87% to $201916.0 in Q4 2021 from the same period last year, while for Dec 2021 it was $201916.0, marking a year-over-year increase of 31981.87%. This contributed to the annual value of $201916.0 for FY2021, which is 31981.87% up from last year.
  • Per Progyny's latest filing, its Gains from Sales and Divestitures stood at $201916.0 for Q4 2021, which was up 31981.87% from $48096.0 recorded in Q4 2020.
  • In the past 5 years, Progyny's Gains from Sales and Divestitures registered a high of $201916.0 during Q4 2021, and its lowest value of $48096.0 during Q4 2020.